FDA Issues Accelerated Approval Draft Guidance for Oncology

The FDA is looking for feedback on its newly published draft guidance on designing cancer drug trials intended for the accelerated approval pathway.
Medscape Medical News

source https://www.medscape.com/viewarticle/990242?src=rss